Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) FCF Margin: 2017-2020

Historic FCF Margin for Cogent Biosciences (COGT) over the last 4 years, with Sep 2020 value amounting to -3,290.71%.

  • Cogent Biosciences' FCF Margin fell 229218.00% to -3,290.71% in Q3 2020 from the same period last year, while for Sep 2020 it was -150.88%, marking a year-over-year increase of 23137.00%. This contributed to the annual value of -455.47% for FY2020, which is 27081.00% down from last year.
  • According to the latest figures from Q3 2020, Cogent Biosciences' FCF Margin is -3,290.71%, which was down 108.73% from -1,576.52% recorded in Q2 2020.
  • In the past 5 years, Cogent Biosciences' FCF Margin registered a high of -55.32% during Q4 2019, and its lowest value of -3,290.71% during Q3 2020.
  • For the 3-year period, Cogent Biosciences' FCF Margin averaged around -749.65%, with its median value being -374.99% (2018).
  • The largest annual percentage gain for Cogent Biosciences' FCF Margin in the last 5 years was 26,638bps (2020), contrasted with its biggest fall of 229,218bps (2020).
  • Cogent Biosciences' FCF Margin (Quarterly) stood at -311.63% in 2017, then surged by 7,458bps to -237.06% in 2018, then surged by 18,173bps to -55.32% in 2019, then plummeted by 229,218bps to -3,290.71% in 2020.
  • Its FCF Margin stands at -3,290.71% for Q3 2020, versus -1,576.52% for Q2 2020 and -112.26% for Q1 2020.